News | November 10, 2021
Pulmatrix resolves dispute with Cipla
Cipla Technologies a subsidiary of Cipla and Pulmatrix had inked a definitive agreement for the co-development and commercialisation of Pulmazole.
Cipla Technologies a subsidiary of Cipla and Pulmatrix had inked a definitive agreement for the co-development and commercialisation of Pulmazole.
Strides Pharma Science has reported consolidated financial results for the period ended September 30, 2021
Bioanalytical approach to accelerate development efforts in the identification of compounds that can treat chlorine or sulfur mustard injuries
It is the world’s first DNA-based Covid vaccine
The new manufacturing facility will be built at a subsidiary of Adcock Ingram and will commence operation in March 23
Trivector Biomed has been promoting its Novaerus air disinfection solution across hospitals and health care facilities across India.
The solution helps the pharma enterprises drive efficiencies, save costs, and increase productivity
The process is completed with the help of a balloon at a low temperature so that other cells are undamaged and the patient can return home the next day
Biocon Biologics and Viatris co-developed the products
Venus Remedies has reported consolidated financial results for the period ended September 30, 2021
Subscribe To Our Newsletter & Stay Updated
